Heather Beckwith

1.5k total citations
22 papers, 365 citations indexed

About

Heather Beckwith is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Heather Beckwith has authored 22 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Cancer Research and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Heather Beckwith's work include Breast Cancer Treatment Studies (9 papers), Cancer Risks and Factors (5 papers) and HER2/EGFR in Cancer Research (5 papers). Heather Beckwith is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Cancer Risks and Factors (5 papers) and HER2/EGFR in Cancer Research (5 papers). Heather Beckwith collaborates with scholars based in United States, Canada and United Kingdom. Heather Beckwith's co-authors include Douglas Yee, Anne Blaes, Jane Yuet Ching Hui, Todd M. Tuttle, Schelomo Marmor, Jing Huang, Scott Kizy, Rachel I. Vogel, David A. Potter and Jianling Yuan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Heather Beckwith

21 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather Beckwith United States 11 180 151 95 68 58 22 365
Gilberto Uemura Brazil 10 230 1.3× 101 0.7× 92 1.0× 83 1.2× 38 0.7× 31 474
Danielle Crawley United Kingdom 12 112 0.6× 117 0.8× 142 1.5× 34 0.5× 146 2.5× 33 381
Jia-Yuan Li China 7 284 1.6× 177 1.2× 55 0.6× 69 1.0× 56 1.0× 11 421
Kirsti Vik Hjerkind Norway 11 200 1.1× 106 0.7× 33 0.3× 34 0.5× 62 1.1× 15 346
Jennifer R. Garreau United States 13 211 1.2× 180 1.2× 77 0.8× 109 1.6× 97 1.7× 23 488
Sayeh Lavasani United States 9 163 0.9× 88 0.6× 57 0.6× 24 0.4× 59 1.0× 24 303
Jun Won Min South Korea 10 155 0.9× 81 0.5× 35 0.4× 28 0.4× 76 1.3× 40 331
A. Gentry-Maharaj United Kingdom 6 63 0.3× 63 0.4× 69 0.7× 60 0.9× 30 0.5× 15 316
Vidar G. Flote Norway 11 186 1.0× 108 0.7× 104 1.1× 22 0.3× 83 1.4× 22 385
Salma Butt Sweden 12 203 1.1× 145 1.0× 90 0.9× 108 1.6× 41 0.7× 21 417

Countries citing papers authored by Heather Beckwith

Since Specialization
Citations

This map shows the geographic impact of Heather Beckwith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Beckwith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Beckwith more than expected).

Fields of papers citing papers by Heather Beckwith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Beckwith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Beckwith. The network helps show where Heather Beckwith may publish in the future.

Co-authorship network of co-authors of Heather Beckwith

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Beckwith. A scholar is included among the top collaborators of Heather Beckwith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Beckwith. Heather Beckwith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Haiyun, Douglas Yee, David A. Potter, et al.. (2024). Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial. Breast Cancer Research and Treatment. 204(3). 589–597. 3 indexed citations
2.
Petersen, Ashley, Heather Beckwith, N Florea, et al.. (2024). Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time. Cardio-Oncology. 10(1). 27–27. 2 indexed citations
3.
Jenkins, Jan, Schelomo Marmor, Jane Yuet Ching Hui, et al.. (2021). The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer. Breast Cancer Research and Treatment. 191(2). 401–407. 8 indexed citations
4.
Wang, Haiyun, Douglas Yee, Saonli Basu, et al.. (2021). Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis. Breast Cancer. 28(3). 618–629. 23 indexed citations
5.
Beckwith, Heather, Diana C. Medgyesy, Jame Abraham, et al.. (2021). Abstract OT-03-03: SGNLVA-001: A phase 1 open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer. Cancer Research. 81(4_Supplement). OT–3. 1 indexed citations
6.
Thomaier, Lauren, Deanna Teoh, Patricia Jewett, et al.. (2020). Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemic. PLoS ONE. 15(11). e0242767–e0242767. 40 indexed citations
7.
Yau, Christina, Heather Beckwith, Katia Khoury, et al.. (2020). Use of 18F-FDG PET/CT as an Initial Staging Procedure for Stage II–III Breast Cancer: A Multicenter Value Analysis. Journal of the National Comprehensive Cancer Network. 18(11). 1510–1517. 21 indexed citations
8.
Beckwith, Heather, Diana C. Medgyesy, Jame Abraham, et al.. (2020). SGNLVA-001: A phase I open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer.. Journal of Clinical Oncology. 38(15_suppl). TPS1104–TPS1104. 5 indexed citations
9.
10.
Ikramuddin, Sayeed, et al.. (2019). The Impact of Bariatric Surgery on Breast Cancer Recurrence: Case Series and Review of Literature. Obesity Surgery. 30(2). 780–785. 19 indexed citations
11.
Yau, Christopher, Lamorna Brown Swigart, Laura Esserman, et al.. (2019). Abstract P3-10-14: LIV-1 expression in primary breast cancers in the I-SPY 2 TRIAL. Cancer Research. 79(4_Supplement). P3–10. 1 indexed citations
12.
Huang, Jing, Scott Kizy, Schelomo Marmor, et al.. (2018). Tumor grade and progesterone receptor status predict 21-gene recurrence score in early stage invasive breast carcinoma. Breast Cancer Research and Treatment. 172(3). 671–677. 20 indexed citations
13.
Kizy, Scott, Jing Huang, Schelomo Marmor, et al.. (2018). Distribution of 21-Gene Recurrence Scores Among Breast Cancer Histologic Subtypes. Archives of Pathology & Laboratory Medicine. 142(6). 735–741. 12 indexed citations
14.
Holtz, Anja, Douglas Yee, & Heather Beckwith. (2018). Abstract 5839: Growth hormone receptor (GHR) expression confers resistance to ruxolitinib in endocrine-resistant breast cancer cells. Cancer Research. 78(13_Supplement). 5839–5839. 2 indexed citations
15.
Marmor, Schelomo, Jane Yuet Ching Hui, Jing Huang, et al.. (2017). Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast. Cancer. 123(16). 3015–3021. 49 indexed citations
16.
Fagan, Dedra H., Svetlana Avdulov, Heather Beckwith, et al.. (2017). Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation. Hormones and Cancer. 8(4). 219–229. 15 indexed citations
17.
Blaes, Anne, Heather Beckwith, N Florea, et al.. (2017). Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study. Breast Cancer Research and Treatment. 166(2). 541–547. 28 indexed citations
18.
Blaes, Anne, Daniel Duprez, Todd E. DeFor, et al.. (2015). Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment. SpringerPlus. 4(1). 32–32. 10 indexed citations
19.
Beckwith, Heather & Douglas Yee. (2015). Minireview: Were the IGF Signaling Inhibitors All Bad?. Molecular Endocrinology. 29(11). 1549–1557. 72 indexed citations
20.
Beckwith, Heather & Douglas Yee. (2014). Insulin-Like Growth Factors, Insulin, and Growth Hormone Signaling in Breast Cancer: Implications for Targeted Therapy. Endocrine Practice. 20(11). 1214–1221. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilberto Uemura Breakdown of academic impact, for papers by Danielle Crawley Breakdown of academic impact, for papers by Jia-Yuan Li Breakdown of academic impact, for papers by Kirsti Vik Hjerkind Breakdown of academic impact, for papers by Jennifer R. Garreau Breakdown of academic impact, for papers by Sayeh Lavasani Breakdown of academic impact, for papers by Jun Won Min Breakdown of academic impact, for papers by A. Gentry-Maharaj Breakdown of academic impact, for papers by Vidar G. Flote Breakdown of academic impact, for papers by Salma Butt
Rankless by CCL
2026